Medigene AG (OTCPK:MDGEF)
$ 2.59 0 (0%) Market Cap: 24.57 Mil Enterprise Value: 12.33 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 53/100

Q4 2020 Medigene AG Earnings Call Transcript

Mar 25, 2021 / 02:00PM GMT
Release Date Price: $8.66
Anna Niedl
Medigene AG - VP, IR & Corporate Communications

Good afternoon and good morning to the US. My name is Anna Niedl. I am responsible for Investor Relations at Medigene. I would like to welcome everybody to today's conference call in which we will describe Medigene's financial and operational results in 2020.

With us today in this conference call are Professor Dolores Schendel, our CEO and CSO at Medigene; Axel Malkomes, the CFO and CBO; and Kai Pinkernell, Chief Medical or CMO and CDO at Medigene.

This is just a call. You can find today's presentation as a download on our website and this call will be recorded and will also be accessible for you later on our website.

So I would like now to draw your attention to slide 2 and would like to remind you that during this call, we will present and discuss certain forward-looking statements as always.

And with this, I would like to hand over to Dolores.

Dolores Schendel
Medigene AG - CEO & Chief Scientific Officer

Thank you, Anna. So let's look at slide 3 and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot